Flow Cytometry
Customize your policy alerts
Sign up for mutualofomaha Policy AHS - F2019 - Flow Cytometry alerts
Get alerted when Policy AHS - F2019 - Flow Cytometry changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage and reimbursement limitations for flow cytometry, including immunophenotyping, cell enumeration, and flow cytometry-derived DNA content or proliferative activity testing. Coverage applies according to the member’s benefit plan and applicable Medicare or Medicaid requirements.
CC2f was edited for clarity.
CC2g was revised to include CPT codes 88184 and 88185 in the incompatibility rule to align with NCCI.
The background, guidelines and recommendations, and evidence-based scientific references were updated.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.